Ken Fisher Astrazeneca PLC Transaction History
Fisher Asset Management, LLC
- $247 Billion
- Q2 2025
A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Astrazeneca PLC stock. As of the latest transaction made, Fisher Asset Management, LLC holds 20,695,979 shares of AZN stock, worth $1.61 Billion. This represents 0.58% of its overall portfolio holdings.
Number of Shares
20,695,979
Previous 20,165,459
2.63%
Holding current value
$1.61 Billion
Previous $1.48 Billion
2.42%
% of portfolio
0.58%
Previous 0.65%
Shares
36 transactions
Others Institutions Holding AZN
# of Institutions
1,414Shares Held
497MCall Options Held
7.11MPut Options Held
2.56M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.04 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.2 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.67 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.44 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.42 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $241B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...